NASDAQ:RIGL

Rigel Pharmaceuticals News Headlines

$4.02
-0.16 (-3.83 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.94
$4.14
50-Day Range
$3.09
$4.18
52-Week Range
$1.74
$5.50
Volume2.60 million shs
Average Volume3.33 million shs
Market Capitalization$684.06 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51

Rigel Pharmaceuticals (NASDAQ RIGL) News Headlines Today

SourceHeadline
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Post Quarterly Sales of $22.08 MillionRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Post Quarterly Sales of $22.08 Million
americanbankingnews.com - June 12 at 3:42 AM
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4.1%Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4.1%
americanbankingnews.com - June 11 at 12:40 PM
 Brokerages Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to Announce -$0.11 Earnings Per Share Brokerages Anticipate Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to Announce -$0.11 Earnings Per Share
americanbankingnews.com - June 10 at 9:18 AM
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Recommendation of "Hold" by BrokeragesRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Recommendation of "Hold" by Brokerages
americanbankingnews.com - June 6 at 5:58 AM
-$0.10 EPS Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter-$0.10 EPS Expected for Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Quarter
americanbankingnews.com - May 22 at 10:22 PM
Rigel Appoints Alison L. Hannah, M.D. to Board of DirectorsRigel Appoints Alison L. Hannah, M.D. to Board of Directors
finance.yahoo.com - May 14 at 8:24 AM
Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue EstimatesRigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue Estimates
nasdaq.com - May 6 at 12:05 AM
Rigel Pharmaceuticals Inc. Bottom Line Rises In Q1Rigel Pharmaceuticals Inc. Bottom Line Rises In Q1
nasdaq.com - May 5 at 7:05 PM
Rigel Pharmaceuticals, Inc.s (NASDAQ:RIGL) Profit OutlookRigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Profit Outlook
finance.yahoo.com - April 20 at 1:19 PM
Is an EUA for Rigel’s COVID-19 Treatment in the Cards? Analyst Weighs InIs an EUA for Rigel’s COVID-19 Treatment in the Cards? Analyst Weighs In
finance.yahoo.com - April 16 at 10:27 PM
Thinking about buying stock in Rigel Pharmaceuticals, Checkpoint Therapeutics, GT Biopharma, ICICI Bank, or Arbutus Biopharma?Thinking about buying stock in Rigel Pharmaceuticals, Checkpoint Therapeutics, GT Biopharma, ICICI Bank, or Arbutus Biopharma?
marketwatch.com - April 13 at 10:51 PM
Why Rigel Pharmaceuticals Stock Jumped TodayWhy Rigel Pharmaceuticals Stock Jumped Today
fool.com - April 13 at 5:38 PM
Rigel Pharma Says Phase 2 Trial Of Fostamatinib For COVID-19 Met Primary Endpoint Of SafetyRigel Pharma Says Phase 2 Trial Of Fostamatinib For COVID-19 Met Primary Endpoint Of Safety
markets.businessinsider.com - April 13 at 7:49 AM
Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19
finance.yahoo.com - April 13 at 7:49 AM
Rigel Announces Closing of Strategic Collaboration with LillyRigel Announces Closing of Strategic Collaboration with Lilly
finance.yahoo.com - April 7 at 8:54 AM
Rigel Completes Patient Enrollment In Phase 2 Trial To Evaluate Fostamatinib In COVID-19 PatientsRigel Completes Patient Enrollment In Phase 2 Trial To Evaluate Fostamatinib In COVID-19 Patients
markets.businessinsider.com - March 11 at 8:14 AM
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 PatientsRigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
finance.yahoo.com - March 11 at 8:14 AM
Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
nasdaq.com - March 7 at 12:46 PM
Rigel Pharmaceuticals (RIGL) CEO Raul Rodriguez on Q4 2020 Results - Earnings Call TranscriptRigel Pharmaceuticals' (RIGL) CEO Raul Rodriguez on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 4 at 9:54 AM
Rigel Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationRigel Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 3 at 8:41 AM
Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) RevenuesNeed To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Revenues
finance.yahoo.com - March 3 at 8:16 AM
EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q4 Earnings ReportEARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. Q4 Earnings Report
nasdaq.com - March 2 at 7:41 PM
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Tops Revenue EstimatesRigel Pharmaceuticals (RIGL) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 2 at 7:41 PM
3 Penny Stocks Outpacing The Market This Week, Time To Buy?3 Penny Stocks Outpacing The Market This Week, Time To Buy?
marketwatch.com - February 25 at 1:28 AM
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business UpdateRigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
finance.yahoo.com - February 23 at 8:30 AM
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
finance.yahoo.com - February 21 at 7:48 AM
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseRigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
nasdaq.com - February 19 at 1:27 PM
RIGL Stock: Why Rigel Pharmaceuticals Is Climbing TodayRIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
investorplace.com - February 18 at 2:51 PM
Peninsula biotech snares $125M upfront payment in drug deal with LillyPeninsula biotech snares $125M upfront payment in drug deal with Lilly
bizjournals.com - February 18 at 2:34 PM
Rigel Pharmaceuticals Rises on Drug Venture With Eli LillyRigel Pharmaceuticals Rises on Drug Venture With Eli Lilly
thestreet.com - February 18 at 2:34 PM
Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15%Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15%
finance.yahoo.com - February 18 at 2:34 PM
Why Rigel Pharmaceuticals Stock Is Jumping TodayWhy Rigel Pharmaceuticals Stock Is Jumping Today
finance.yahoo.com - February 18 at 2:34 PM
Lilly, Rigel To Develop RIPK1 Inhibitors For Treatment Of Immunological & Neurodegenerative DiseasesLilly, Rigel To Develop RIPK1 Inhibitors For Treatment Of Immunological & Neurodegenerative Diseases
nasdaq.com - February 18 at 9:34 AM
Rigel Higher on Immunology-Drug Venture With Eli LillyRigel Higher on Immunology-Drug Venture With Eli Lilly
msn.com - February 18 at 9:34 AM
Rigel Pharma shares soar 39% premarket on news of deal with Eli LillyRigel Pharma shares soar 39% premarket on news of deal with Eli Lilly
finance.yahoo.com - February 18 at 9:34 AM
UPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mlnUPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mln
finance.yahoo.com - February 18 at 9:34 AM
Rigel receives $16.5M for Phase 3 clinical trial of Fostamatinib in COVID-19 patientsRigel receives $16.5M for Phase 3 clinical trial of Fostamatinib in COVID-19 patients
seekingalpha.com - January 31 at 7:58 AM
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 PatientsRigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
finance.yahoo.com - January 29 at 5:23 PM
If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You Could Pocket A 49% Gain TodayIf You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You Could Pocket A 49% Gain Today
finance.yahoo.com - January 29 at 12:23 PM
Rigel Pharma Says TAVALISSE Preliminary 2020 Net Product Sales Up 41% - Quick Facts Rigel Pharma Says TAVALISSE Preliminary 2020 Net Product Sales Up 41% - Quick Facts
markets.businessinsider.com - January 11 at 8:04 AM
Rigel to Present at the 39th Annual J.P. Morgan Healthcare ConferenceRigel to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 8:39 AM
Rigel PharmaceuticalsRigel Pharmaceuticals
fool.com - January 1 at 12:14 AM
RIGL Feb 2021 5.000 callRIGL Feb 2021 5.000 call
uk.finance.yahoo.com - December 27 at 10:00 PM
RIGL Mar 2021 10.000 putRIGL Mar 2021 10.000 put
uk.finance.yahoo.com - December 27 at 10:00 PM
Is the Options Market Predicting a Spike in Rigel Pharmaceuticals (RIGL) Stock?Is the Options Market Predicting a Spike in Rigel Pharmaceuticals (RIGL) Stock?
finance.yahoo.com - December 21 at 1:59 PM
Is RIGL A Good Stock To Buy Now According To Hedge Funds?Is RIGL A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 19 at 11:25 PM
What Type Of Shareholders Own The Most Number of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?What Type Of Shareholders Own The Most Number of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares?
finance.yahoo.com - December 15 at 11:32 AM
Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & ExpositionRigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition
finance.yahoo.com - December 4 at 8:57 AM
Health Canada OKs Rigel Pharmas Tavalisse for low blood plateletsHealth Canada OK's Rigel Pharma's Tavalisse for low blood platelets
seekingalpha.com - November 23 at 1:22 PM
Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune ThrombocytopeniaRigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia
finance.yahoo.com - November 23 at 8:21 AM
This page was last updated on 6/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.